Micro- and Nano-Systems Developed for Tolcapone in Parkinson’s Disease

To date there is no cure for Parkinson’s disease (PD), a devastating neurodegenerative disorder with levodopa being the cornerstone of its treatment. In early PD, levodopa provides a smooth clinical response, but after long-term therapy many patients develop motor complications. Tolcapone (TC) is an...

Descripción completa

Detalles Bibliográficos
Autores principales: Casanova, Yaquelyn, Negro, Sofía, Slowing, Karla, García-García, Luis, Fernández-Carballido, Ana, Rahmani, Mahdieh, Barcia, Emilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143005/
https://www.ncbi.nlm.nih.gov/pubmed/35631665
http://dx.doi.org/10.3390/pharmaceutics14051080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143005/
https://www.ncbi.nlm.nih.gov/pubmed/35631665
http://dx.doi.org/10.3390/pharmaceutics14051080

Ejemplares similares